 |
|
midostaurin
A synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platelet-derived growth factor receptor (PDGFR) and FMS-like tyrosine kinase 3 (FLT3) tyrosine kinases, which may result in disruption of the cell cycle, inhibition of proliferation, apoptosis, and inhibition of angiogenesis in susceptible tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | N-benzoyl-staurosporine | | | | Code name: | | PKC412 | | |
|
|
